A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP3700 in Healthy Male Subjects
Clinical trial NCT02155504 · COMPLETED
Trial details
- NCT number
- NCT02155504
- Sponsor
- Astellas Pharma Europe B.V.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2014-10-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.